These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
667 related items for PubMed ID: 16253930
1. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes. Antzelevitch C. Heart Rhythm; 2005 Nov; 2(2 Suppl):S9-15. PubMed ID: 16253930 [Abstract] [Full Text] [Related]
2. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. Antzelevitch C. Europace; 2007 Sep; 9 Suppl 4(Suppl 4):iv4-15. PubMed ID: 17766323 [Abstract] [Full Text] [Related]
3. Arrhythmogenic mechanisms of QT prolonging drugs: is QT prolongation really the problem? Antzelevitch C. J Electrocardiol; 2004 Sep; 37 Suppl():15-24. PubMed ID: 15534788 [Abstract] [Full Text] [Related]
4. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome. Antzelevitch C, Yan GX, Shimizu W. J Electrocardiol; 1999 Sep; 32 Suppl():158-65. PubMed ID: 10688320 [Abstract] [Full Text] [Related]
5. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs). Lu HR, Yan GX, Gallacher DJ. J Pharmacol Toxicol Methods; 2013 Sep; 68(2):250-259. PubMed ID: 23337247 [Abstract] [Full Text] [Related]
6. Cellular mechanisms underlying the long QT syndrome. Antzelevitch C, Shimizu W. Curr Opin Cardiol; 2002 Jan; 17(1):43-51. PubMed ID: 11790933 [Abstract] [Full Text] [Related]
7. Cellular basis for QT dispersion. Antzelevitch C, Shimizu W, Yan GX, Sicouri S. J Electrocardiol; 1998 Jan; 30 Suppl():168-75. PubMed ID: 9535495 [Abstract] [Full Text] [Related]
8. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. Antzelevitch C, Sun ZQ, Zhang ZQ, Yan GX. J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574 [Abstract] [Full Text] [Related]
9. Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation. Di Diego JM, Belardinelli L, Antzelevitch C. Circulation; 2003 Aug 26; 108(8):1027-33. PubMed ID: 12912819 [Abstract] [Full Text] [Related]
10. Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: torsades de pointes develops with halothane but not pentobarbital anesthesia. Weissenburger J, Nesterenko VV, Antzelevitch C. J Cardiovasc Electrophysiol; 2000 Mar 26; 11(3):290-304. PubMed ID: 10749352 [Abstract] [Full Text] [Related]
11. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Medina-Ravell VA, Lankipalli RS, Yan GX, Antzelevitch C, Medina-Malpica NA, Medina-Malpica OA, Droogan C, Kowey PR. Circulation; 2003 Feb 11; 107(5):740-6. PubMed ID: 12578878 [Abstract] [Full Text] [Related]
12. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Shimizu W, Antzelevitch C. Circulation; 1998 Nov 24; 98(21):2314-22. PubMed ID: 9826320 [Abstract] [Full Text] [Related]
13. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome. Shimizu W, McMahon B, Antzelevitch C. J Cardiovasc Electrophysiol; 1999 Feb 24; 10(2):154-64. PubMed ID: 10090218 [Abstract] [Full Text] [Related]
14. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Shimizu W, Antzelevitch C. Circulation; 1997 Sep 16; 96(6):2038-47. PubMed ID: 9323097 [Abstract] [Full Text] [Related]
15. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Circulation; 1992 Nov 16; 86(5):1376-82. PubMed ID: 1423949 [Abstract] [Full Text] [Related]
16. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing. Fish JM, Di Diego JM, Nesterenko V, Antzelevitch C. Circulation; 2004 May 04; 109(17):2136-42. PubMed ID: 15078801 [Abstract] [Full Text] [Related]
17. Use of preclinical assays to predict risk of drug-induced torsades de pointes. Belardinelli L, Shryock JC, Wu L, Song Y. Heart Rhythm; 2005 Nov 04; 2(2 Suppl):S16-22. PubMed ID: 16253927 [Abstract] [Full Text] [Related]
18. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Yan GX, Antzelevitch C. Circulation; 1998 Nov 03; 98(18):1928-36. PubMed ID: 9799215 [Abstract] [Full Text] [Related]
19. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine. Sicouri S, Timothy KW, Zygmunt AC, Glass A, Goodrow RJ, Belardinelli L, Antzelevitch C. Heart Rhythm; 2007 May 03; 4(5):638-47. PubMed ID: 17467634 [Abstract] [Full Text] [Related]
20. Transmural dispersion of repolarization as a preclinical marker of drug-induced proarrhythmia. Said TH, Wilson LD, Jeyaraj D, Fossa AA, Rosenbaum DS. J Cardiovasc Pharmacol; 2012 Aug 03; 60(2):165-71. PubMed ID: 22561361 [Abstract] [Full Text] [Related] Page: [Next] [New Search]